Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 42Congress 0Executive branch 0Insiders 42
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

SYRE · $100K+ · 42 trades

Trades
42
Buys 0 · Sells 42
People
10
Stocks
1
Disclosed value
$1.6B
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$681Kdisclosed Aug 5 · filed 2 days after the trade
  2. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$486Kdisclosed Aug 5 · filed 2 days after the trade
  3. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$541Kdisclosed Aug 5 · filed 2 days after the trade
  4. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$135Kdisclosed Aug 5 · filed 2 days after the trade
  5. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$152Kdisclosed Jul 2 · filed 1 day after the trade
  6. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$506Kdisclosed Jul 2 · filed 1 day after the trade
  7. ▼ SELLSheldon Sloan Chief Medical OfficerSYRE Spyre Therapeutics, Inc.$569Kdisclosed Jul 2 · filed 1 day after the trade
  8. ▼ SELLSheldon Sloan Chief Medical OfficerSYRE Spyre Therapeutics, Inc.$162Kdisclosed Jul 2 · filed 1 day after the trade
  9. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$890Kdisclosed Jul 2 · filed 1 day after the trade
  10. ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$373Kdisclosed Jul 2 · filed 1 day after the trade
  11. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$871Kdisclosed Jun 26 · filed 1 day after the trade
  12. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$436Kdisclosed Jun 26 · filed 1 day after the trade
  13. ▼ SELLMichael Thomas Henderson DirectorSYRE Spyre Therapeutics, Inc.$2Mdisclosed Jun 23 · filed 1 day after the trade
  14. ▼ SELLPeter Evan Harwin DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  15. ▼ SELLTomas Kiselak DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  16. ▼ SELLFairmount Funds Management LLC DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  17. ▼ SELLFairmount Healthcare Fund II L.P. DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day